Reviva Pharmaceuticals
RVPH
RVPH
33 hedge funds and large institutions have $14.9M invested in Reviva Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7.43% more ownership
Funds ownership: 22.58% → 30.01% (+7.4%)
6% more funds holding
Funds holding: 31 → 33 (+2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
33
Holding in Top 10
–
Calls
$422K
Puts
$132K
Top Buyers
| 1 | +$3.54M | |
| 2 | +$657K | |
| 3 | +$558K | |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$66.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$51.3K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$263K | |
| 3 | -$145K | |
| 4 |
ECM
EMC Capital Management
Houston,
Texas
|
-$117K |
| 5 |
Morgan Stanley
New York
|
-$13.1K |